1 / 39

HORIZON 2020 The EU Framework Programme for Research and Innovation 2014-2020

HORIZON 2020 The EU Framework Programme for Research and Innovation 2014-2020. Presentation to NUI Galway 10 September 2013 Kay Duggan-Walls, Health Research Board National Contact Point for Horizon 2020 Health. Proposal for H2020.

rea
Download Presentation

HORIZON 2020 The EU Framework Programme for Research and Innovation 2014-2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HORIZON 2020 The EU Framework Programme for Research and Innovation 2014-2020 Presentation to NUI Galway 10 September 2013 Kay Duggan-Walls, Health Research Board National Contact Point for Horizon 2020 Health

  2. Proposal for H2020 Legislative proposal from Commission was announced 30 November 2011 Part of a drive to create new jobs and growth in Europe

  3. What is Horizon 2020? • Commission proposal for a €80 billion research and innovation funding programme (2014-2020) • A core part of Europe 2020, Innovation Union & European Research Area: • Responding to the economic crisis to invest in future jobs and growth • Addressing people’s concerns about their livelihoods, safety and environment • Strengthening the EU’s global position in research, innovation and technology

  4. Horizon 2020 – What’s New • A single programmebringing together three separate programmes/initiatives* • Coupling research to innovation – from research to retail, all forms of innovation • Focus on societal challenges facing EU society, e.g. health, clean energy and transport • Simplified access, for all companies, universities, institutes in all EU countries and beyond *The 7th Research Framework Programme (FP7), innovation aspects of Competitiveness and Innovation Framework Programme (CIP), EU contribution to the European Institute of Innovation and Technology (EIT)

  5. Three Priorities • Excellent Science • Industrial leadership • Societal challenges

  6. Priority 1. Excellent science€25bn Why: • World class science is the foundation of tomorrow’s technologies, jobs and well-being • Europe needs to develop, attract and retain research talent • Researchers need access to the best infrastructures

  7. Priority 2. Industrial leadership€18bn Why: • Strategic investments in key technologies (e.g. advanced manufacturing, micro-electronics) innovation across existing and emerging sectors. • Europe needs to attract more private investment in research and innovation • Europe needs more innovative SMEs to create growth and jobs

  8. Priority 3. Societal challenges€32bn Why: • Concerns of citizens and society/EU policy objectives (climate, environment, energy, transport etc.) cannot be achieved without innovation • Breakthrough solutions come from multi-disciplinary collaborations, including social sciences & humanities • Promising solutions need to be tested, demonstrated and scaled up

  9. Horizon 2020

  10. Horizon 2020 and partnering: an overview Public private partnerships • Through Joint Technology Initiatives (JTIs) or other formal structures (Art 187) • Through contractual agreements, which provide input for work programmes • Only when criteria met, e.g. clear commitment from private partners Public public partnerships: • Through ‘ERA-Nets’ for topping up individual calls/actions (replacing current ERA-Net, ERA-Net Plus, Inco-Net, Inno-net) • Through participation in joint programmes between Member States (Art. 185) • Supporting agendas of Joint Programming Initiatives when in line with Horizon 2020 • Only when criteria met, e.g. financial commitments of participating countries European Innovation Partnerships • Not funding instruments, but for coordination with broader policies and programmes

  11. FP7 Cooperation themes → HORIZON2020 challenges • Health (€6.1b) • Food, agriculture, fisheries and biotechnology • Information and communication technologies • Nanosciences, nanotechnologies, materials and new production technologies • Energy • Environment (including climate change) • Transport (including aeronautics) • Socio-economic sciences and the humanities • Security • Space • The Health, Demographic Change and Well-being Challenge (€7bn over 7 yrs) • The Food Security and Bio-based Economy Challenge • The Secure, Clean and Efficient Energy Challenge • The Smart, Green and Integrated Transport challenge • The Resource Efficiency and Climate Challenge • The Inclusive, Innovative and Secure Societies Challenge

  12. The Health, Demographic Change and Well-being Challenge • Basic research through translation of knowledge, to large trials and demonstration actions • Broader scope than FP7 • More ICT aspects • Public procurement for new products, services, scalable solutions (interoperable and supported by defined standards and/or common guidelines) – haven’t had this before in Health

  13. Specific activities proposed 1.1. Understanding health, wellbeing and disease 1.1.1. Understanding the determinants of health, improving health promotion and disease prevention 1.1.2. Understanding disease 1.1.3. Improving surveillance and preparedness 1.2. Preventing disease 1.2.1. Developing effective  prevention and screening programmes and improving the assessment of disease susceptibility 1.2.2. Improving diagnosis and prognosis 1.2.3. Developing better preventive and therapeutic vaccines 1.3. Treating and managing disease 1.3.1. Treating disease, including developing regenerative medicine 1.3.2. Transferring knowledge to clinical practice and scalable innovation actions

  14. Specific Activities proposed 1.4. Active ageing and self-management of health 1.4.1. Active ageing, independent and assisted living 1.4.2. Individual awareness and empowerment for self-management of health 1.5. Methods and data 1.5.1. Improving health information and better use of health data 1.5.2. Improving scientific tools and methods to support policy making and regulatory needs 1.5.3. Using in-silico medicine for improving disease management and prediction 1.6. Health care provision and integrated care 1.6.1. Promoting integrated care 1.6.2. Optimising the efficiency and effectiveness of healthcare provision and reducing inequalities by evidence based decision making and dissemination of best practice, and innovative technologies and approaches

  15. Proposed Work Programme Cycle

  16. Strategic Programme for the 2014-2016 Work Programme

  17. Horizon 2020 Work Programme Horizon 2020 is different • Multidisciplinary approach • Strong challenge based approach – allowing applicants freedom to come up with innovative solutions • Simplified list of possible type of action (research and innovation 100%; innovation actions – 70%) • Less prescription, strong emphasis on expected impact • Broader topics • Cross-cutting issues mainstreamed (e.g. social science, gender)

  18. Personalised Health and Care • Choice to focus on personalised health and care – informed by ageing of the European population • Increasing communicable and non-communicable disease burden • Fall out from economic crisis • Aims to create opportunities for real breakthrough research and radical innovation • Supporting translational of findings into clinic and other healthcare settings to improve health outcomes, reduce inequalities and promote active and healthy ageing

  19. Rational for 1st Work Programme • Demographic changes • Chronic diseases • Sustainability of health and care systems – cost of inaction • Drug development pipeline • Infectious disease – in terms of global development, resurgence, pandemic threat • Big data

  20. Work programme Topics Structure reflects the challenge based approach • Specific Challenge – sets the context, the problem to be addressed, why intervention is necessary • Scope – delineates the problem, specifies the focus and the boundaries of the potential action BUT without overtly describing specific approaches • Expected Impact – describe the key elements of what is expected to be achieved in relation to the specific challenge

  21. Work Programme Summary • Understanding health, ageing and disease – 2 topics • Effective health promotion, disease prevention, preparedness and screening – 6 topics • Improving diagnostics – 3 topics • Innovative treatments and technologies – 6 topics • Advancing active and healthy ageing – 3 topics • Integrated, sustainable, citizen-centred care – 7 topics • Improving health information, data exploitation and providing an evidence-base for health policies and regulation – 5 topics

  22. Work Programme • Societal challenge ‘Health demographic change and wellbeing’ • 2014 & 2015, 32 topics the ‘personalised health and care’ focus area call • 10 topics in the ‘co-ordination activities’ call

  23. Work Programme Topics • PCH 1 – 2014 Understanding health, ageing and disease: determinants, risk factors and pathways • PCH 2 – 2015 Understanding health, ageing and disease: systems medicine • PCH 3 – 2015 Health promotion and disease prevention: improved inter-sector cooperation for environment and health based interventions • PHC 4 – 2015 Health promotion and disease prevention: translating ‘omics’ into stratified approaches

  24. Work Programme Topics cont. • PHC 5 – 2014 Evaluating existing screening and prevention programmes • PHC 6 – 2014 Improving the control of infectious epidemics and foodborne outbreaks through rapid identification of pathogens • PHC 7 – 2014 Vaccine development for poverty-related and neglected infectious diseases: Tuberculosis • PHC 8 – 2015 Vaccine development for poverty-related and neglected infectious diseases – HIV/AIDS • PHC 9 – 2014 Development of new diagnostic tools and technologies: in vitro devices, assays and platforms • PHC 10 – 2015 Development of new diagnostic tools and technologies: in vivo medical imaging technologies

  25. Work Programme cont. • PHC 11 – 2014 and 2015 Clinical validation of biomarkers • PHC 12 – 2014 New therapies for chronic and non-communicable diseases • PHC 13 – 2015 New therapies for rare diseases • PHC 14 – 2014/15 Clinical research on regenerative medicine • PHC 15 – 2015 Tools and technologies for advanced therapies • PHC 16 – 2014 Comparing the effectiveness of existing healthcare interventions in the elderly

  26. Work Programme cont. • PHC 17 -2015 Establishing effectiveness of health care interventions in the paediatric population • PHC 18 – 2014 Advancing active and healthy ageing with ICT: Service robotics within assisted living environments; and ICT solutions for independent living with cognitive impairment • PHC 19 – 2015 Advancing active and healthy ageing with ICT: Early risk detection and intervention • PHC 20 – 2015 Promoting mental wellbeing: in the ageing population

  27. Work Programme cont. • PHC 21 – 2014 Developing and comparing new models for safe and efficient, prevention orientated, health and care systems • PHC 22 – 2015 Piloting personalised medicine in health and care systems • PHC 23 – 2015 Advanced ICT systems and services for integrated care • PHC 24 – 2014 Self-management of health and disease: citizen engagement and mHealth • PHC 25 – 2015 Self-management of health and disease: decisional support systems and patient empowerment supported by ICT • PHC 26 – 2015 Public procurement of innovative eHealth services

  28. Work Programme cont. • PHC 27 201? eHealthSectoral Prize • PHC 28 – 2015 Digital representation of health data to improve diseases’ diagnosis and treatment • PHC 29 – 2014 Foresight for health policy development and regulation • PHC 30 – 2014 Advancing bioinformatics to meet biomedical and clinical needs • PHC 31 – 2015 New approaches to improve predictive human safety testing • PHC 32 – 2014 eHealth interoperability

  29. Co-ordination activities • HCO 1 - 2014 Innovative Partnership: Support for the European Innovative Partnership on Active and Health ageing • HCO 2 – 2014 Joint Programming: Coordination Action for the Joint Programming Initiative (JPI) ‘More Years, Better Lives – the Challenges and Opportunities of Demographic Change’ • HCO 3 – 201? Support for the European Reference Networks: Efficient network modelling and validation • HCO 4 – 2014 Support for international infectious disease preparedness research • HCO 5 – 201? Global Alliance for Chronic Diseases: Prevention and treatment type 2 diabetes

  30. ERA-NETs • HCO 6 – 2014 ERA-NET Establishing synergies between the Joint Programming on Neurodegenerative Disease Research and Horizon 2020 • HCO 7 – 2014 ERA-NET: Cancer research programmes and activities • HCO 8 – 2014 ERA-NET: Brain related diseases research programmes and activities • HCO 9 – 2014 ERA-NET: Systems medicine for clinical needs research programme and activities • HCO 10 – 201? ERA-NET: Rare disease research implementing IRDiRC objectives

  31. Budget • Horizon 2020 - €70bn over 7 years • SC1 (health) - €7bn over 7 years first 2 years – only€1bn across 32 topics • 15% of budget ICT topics • 1/3 of funding will be provided for ERA-NETs

  32. Horizon 2020 is different • Web portal with one entrance for the Programme • Counting on MS to explain to researchers – need to look at entirety of the programme not just SC1 • ERC – increase in budget to €15.6bn- 20% ~ life sciences – may be first port of call • Encouraged to look at other schemes

  33. Timeline • Commission published Horizon 2020 package on 30 Nov 2011 • Council agreed ‘Partial General approaches’ on Regulation in May; on the Rules in October and the Specific Programme in December 2012 • The ITRE Committee of Parliament proposed amendments in November 2012 • ‘Adoption of Horizon 2020 legislative acts expected at end 2013 • First calls: expected mid-December • Structure H2020 programme committees to be agreed • Health Advisory Groups to be established • Nominations for NCPs have been sought

  34. Ireland’s Results FP7 Health • 490 participations • 28 successful coordinators • 117 successful partners • 15.5% funding ~ 4 clinical trials projects • Total funding in FP7 Health - €77.68m • Ireland target €600 million ~ €502 million • Health target 1.25% - exceeded 1.7%

  35. Ireland’s FP7 Health Participation 2007-2013 €77.68m ** TS = Two stage , $at second stage, #Innovation 1 call, &Innovation 2 call (SME focused), ¥Some projects have multiple Irish Partners, ‡ Highest success rate for coordinators in EU (71.4%)

  36. Health NCPs for Ireland • Kay Duggan-Walls Health Research Board kdugganwalls@hrb.ie • Ciaran Duffy Enterprise Ireland Ciaran.duffy@enterprise-ireland.com • Patricia Clarke (National Delegate) Health Research Board pclarke@hrb.ie • Meet regularly – meetings/teleconference/email

  37. For further information contact Kay Duggan-Walls kdugganwalls@hrb.ie tel (01) 2345 187

More Related